94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
Mugahed Abdullah Hasan Albahde1,2,3,4†
Bulat Abdrakhimov5†Guo-Qi Li1,2Xiaohu Zhou1,2Dongkai Zhou1,2Hao Xu1,2Huixiao Qian1,2
Weilin Wang1,2,3,4,6*- 1Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
- 2Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, Hangzhou, China
- 3Research Center of Diagnosis and Treatment Technology for Hepatocellular Carcinoma of Zhejiang Province, Hangzhou, China
- 4Clinical Medicine Innovation Center of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Disease of Zhejiang University, Hangzhou, China
- 5Department of Cardiovascular Surgery, Renmin Hospital of Wuhan University, Wuhan, China
- 6Clinical Research Center of Hepatobiliary and Pancreatic Diseases of Zhejiang Province, Hangzhou, China
A Corrigendum on
The role of microtubules in pancreatic cancer: therapeutic progress
By Albahde MAH, Abdrakhimov B, Li GQ, Zhou X, Zhou D, Xu H, et al. Front Oncol (2021) 11:640863. doi: 10.3389/fonc.2021.640863
In the published article, there was an error in the affiliation of Bulat Abdrakhimov. Instead of “Clinical Medicine Innovation Center of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Disease of Zhejiang University, Hangzhou, China” (affiliation #4), it should be “Department of Cardiovascular Surgery, Renmin Hospital of Wuhan University” (affiliation #5).
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: pancreatic ductal adenocarcinoma, microtubule-targeting agents, microtubules, pancreatic cancer, drugs
Citation: Albahde MAH, Abdrakhimov B, Li G-Q, Zhou X, Zhou D, Xu H, Qian H and Wang W (2024) Corrigendum: The role of microtubules in pancreatic cancer: therapeutic progress. Front. Oncol. 14:1414456. doi: 10.3389/fonc.2024.1414456
Received: 08 April 2024; Accepted: 09 April 2024;
Published: 01 May 2024.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2024 Albahde, Abdrakhimov, Li, Zhou, Zhou, Xu, Qian and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Weilin Wang, d2FtQHpqdS5lZHUuY24=
†These authors have contributed equally to this work